{"id":"W4379282509","doi":"10.1200/jco.2023.41.16_suppl.4025","title":"Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 3-year follow-up from CheckMate 649.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Nivolumab; Internal medicine; Oncology; Ipilimumab; FOLFOX; Cancer; Gastroesophageal Junction; Randomized controlled trial; Overall survival; Adenocarcinoma; Immunotherapy; Oxaliplatin; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001245101,0.0005848996,0.001175309,0.0003097529,0.0002653659,0.0005951086,0.0006175619,0.000795415,0.002651562],"category_scores_gemma":[0.0007932275,0.0002809785,0.001073693,0.0002825562,0.000564594,0.0004815781,0.0003496759,0.001225159,0.0003649523],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001150224,"about_ca_system_score_gemma":0.0009606682,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001190682,"about_ca_topic_score_gemma":0.003394668,"domain_scores_codex":[0.999592,0.0001907533,0.0000282121,0.00007267907,0.00003095321,0.00008539613],"domain_scores_gemma":[0.9994243,0.0001164626,0.0001701143,0.00003755247,0.00002220137,0.0002293916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9411665,0.01207012,0.005614232,0.0003680223,0.0008342702,0.00005678014,0.00006536806,0.0009931852,0.00528573,0.0000795727,0.0007022999,0.03276383],"study_design_scores_gemma":[0.3902985,0.5641715,0.03471417,0.00007945007,0.001920136,0.000131837,0.00006197688,0.001825133,0.004133215,0.0002093045,0.002422319,0.0000325402],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9966159,0.001102379,0.000106929,0.00009110657,0.00006797697,0.0007829659,0.0004749011,0.00002300036,0.0007348658],"genre_scores_gemma":[0.9972566,0.0004538767,0.0002512071,0.0002004391,0.0000633366,0.0005524635,0.0004702861,0.000004921478,0.0007469942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002651562,"threshold_uncertainty_score":0.008870363,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08883121524277672,"score_gpt":0.4229260085238555,"score_spread":0.3340947932810788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}